article thumbnail

Upcoming EveryLife Foundation Scientific Workshop on May 21, 2024 will Address Challenges in Developing Therapies for Ultra-Rare Diseases

FDA Law Blog: Drug Discovery

By Sarah Wicks — On May 21, 2024, the EveryLife Foundation for Rare Diseases (ELF) will host a Scientific Workshop at the National Press Club in Washington, D.C. The workshop is free to attend and available to all. More information on the Scientific Workshop can be found here and registration for the live-stream can be found here.

Disease 59
article thumbnail

TDR and WHO launch a new digital health research toolkit for TB care

The Pharma Data

TDR, in partnership with the WHO Global Tuberculosis Programme, has developed an interactive web-based toolkit that supports national TB programmes and other partners to conduct implementation research designed to evaluate digital technologies for TB care. This will be launched today at a workshop taking place in Beijing, China.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Workshop addresses oncology dose optimization across full span of development

Agency IQ

BY CHELSEY MCINTYRE, PHARMD , KARI OAKES In a series of broad-ranging, frank discussions, attendees at a joint FDA-American Association of Cancer Research (AACR) workshop worked through opportunities and challenges for dose optimization across the span of cancer drug development activities.

FDA 59
article thumbnail

Perficient’s Sitecore Personalize Decision Model Workshop

Perficient: Drug Development

.” When it comes to personalization, all too often organizations employ tactics alone, despite a ton of effort being fed into strategic initiatives including customer journey mapping, persona development and user research. Interested in learning more? Reach out to me on LinkedIn , Twitter or fill out our contact form.

article thumbnail

FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids

The Pharma Data

director of the FDA’s Center for Drug Evaluation and Research. The workshop is being convened by the Duke-Margolis Center for Health Policy and supported by a cooperative agreement between the FDA and Duke-Margolis. The following quote is attributed to Patrizia Cavazzoni, M.D.,

FDA 52
article thumbnail

Keypoint Newsletter: Health Equity Programming

keypoint

New this year we added new Health Equity Programming to select meetings, to raise awareness for health disparities in various fields, and initiate discussions on how to rectify these health inequities through scientific research and discovery. Three meetings in 2023 featured health equity speakers and workshops.

article thumbnail

Perficient Recognized for Salesforce Expertise: Helping Businesses Thrive

Perficient: Drug Development

Thats where independent research from trusted industry analysts comes inhelping businesses identify top-performing partners that drive real results. Were excited to share that Perficient was recently recognized by a leading global technology research and advisory firm as a standout Salesforce ecosystem partner in the U.S.